WHO recommendations for influenza virus vaccine composition for the 2018-2019 Northern hemisphere season
Low uptake of seasonal influenza vaccination in Europe may jeopardise capacity to protect people in next pandemic
- Weekly influenza update
- Influenza Virus Characterisations Reports, summary Europe
- Disease data from ECDC Surveillance Atlas
- Seasonal overviews of influenza in Europe
- Annual epidemiological reports
- National, regional and global influenza surveillance reports
- Facts about influenza surveillance
- ECDC publications and peer-reviewed articles
Microbiology and laboratory reports; External quality assessments, Influenza virus characterisations.
E-learning course on how to increase influenza vaccination uptake. This e-learning course has been developed since seasonal influenza vaccination of HCWs is recommended in Europe but vaccination uptake remains low in most countries.
- Why is pandemic preparedness planning important?
- Influenza pandemic preparedness plans
- Guide to revision of national pandemic influenza preparedness plans
- Guide to public health measures to reduce the impact of influenza pandemics in Europe
- European pandemic preparedness timeline
- Innovations in influenza pandemic preparedness
- Assessment tool for influenza pandemic preparedness
Key outputs season 2017-18
Influenza in Europe, season 2017-2018
See updates from ECDC and key partners on surveillance data and other developments for the influenza 2017-2018 season. The updates are syndicated from the official account of the European Centre for Disease Prevention and Control's Influenza and other Respiratory Viruses programme (@ECDC_Flu).See updates
Joint ECDC-WHO/Europe weekly influenza update
In collaboration with WHO Regional Office for Europe, ECDC monitors and reports on influenza activity in Europe on a weekly basis throughout the flu season in the report Flu News Europe.
Go to the report
Influenza Virus Characterisations Reports, summary Europe
The ECDC Influenza Virus Characterisations Reports are published periodically. The report provides an overview of the technical details of the circulating influenza viruses, such as antigenic and genetic properties, with a reference to the current vaccine strains. It also summaries the developments of the viruses since the last report, as well as the main developments for the ongoing season. The report is of special interest for influenza virologists and epidemiologists interested in the in-depth characterisation of influenza viruses.Read more
Risk assessment for seasonal influenza, EU/EEA, 2017–2018
20 Dec 2017 - First detections indicated circulation of A(H3N2) and B/Yamagata viruses. As the former subtype dominated last season, a high proportion of the population should be protected. However, the emergence of variant strains cannot be excluded and this would increase the likelihood of severe outcomes in the elderly
Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses
14 Aug 2017 - This ECDC expert opinion confirms earlier assessments by ECDC and national authorities that there is no significant new evidence to support any changes to the approved indications and recommended use of neuraminidase inhibitors (NAIs) in EU/EEA Member States.
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza?
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Published in the Science, 36 (4), 25 Jan 2018.Read the article
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness
Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018. Published in Eurosurveillance, 23 (5), 01 Feb 2018.Go to the article
ECDC disease programmes and networks
European Influenza Surveillance Network (EISN)
The network combines epidemiological and virological surveillance of influenza.Read more
European Reference Laboratory Network for Human Influenza (ERLI-Net)
The ERLI-Net sub-network of reference laboratories of the European Influenza Surveillance Network carries out virological surveillance of human influenza in the EU/EEA through the EISN timely reporting mechanism and strengthening laboratory capacity for influenza virus detection, antiviral susceptibility testing and typing.Read more
Other types of respiratory tract infections
2009 influenza A (H1N1) pandemic
The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza.Read more
Enteroviruses are a group of viruses that cause a number of infectious illnesses which are usually mild. However if they infect the central nervous system, they can cause serious illness. The two most common ones are echovirus and coxsackievirus, but there are several others.Read more
Middle East respiratory syndrome coronavirus (MERS-CoV)
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a new beta virus strain of an animal coronavirus that was first identified in Saudi Arabia in September 2012. This novel coronavirus differs from the previously identified coronaviruses such as the SARS coronavirus (SARS-CoV), which caused the 2003 SARS outbreaks.Read more
Severe acute respiratory syndrome (SARS)
Severe acute respiratory syndrome (SARS) is a life-threatening respiratory disease caused by a recently identified coronavirus; the SARS-associated coronavirus (SARS-CoV). This is believed to be an animal virus that recently crossed the species barrier to infect humans.Read more